About Umbilical Cord Blood Treatment Abroad
This information is intended for general information only and should not be considered as medical advice on the part of Health-Tourism.com. Any decision on medical treatments, after-care or recovery should be done solely upon proper consultation and advice of a qualified physician.
How is the procedure performed?
Our regenerative procedure involves the intravenous infusion
of donated cord blood cells in an out-patient setting. In order to maximize
therapeutic effect, a dose of greater than 50 million cord blood cells per kg
of body weight from 4 to 8 donors is infused in each procedure, and the cord
blood infusions are generally administered over the course of 2 to 3 days
(about 3 hours/day). During and after each infusion, patients are attended by
doctors and medical staff for close monitoring.
CBC Health AG treatment with high-dose of donated umbilical
cord blood cells shows response rates of about 85% in patients within first two
years after onset of cerebral ischemia. Cord blood regenerative therapy results
in improvement on neurological and functional levels. The sooner the cord blood
treatment is applied in parallel with neurorehabilitation, the better the
Surgeon: Dr. Nils H. Thoennissen MD
June 2020 at 13:22 UTC
Updated: 08 June 2020 at 15:26 UTC
Duration of procedure/surgery : After one day of thorough clinical examination, the cord blood infusions are generally administered over the course of 2 to 3 days in an out-patient setting. The day after the treatment a final check-
Days admitted : 4 - 5 days max.
Recovery : Patients begin to notice improvements within a few weeks after the infusion. The cord blood cells are eliminated from the patient’s body within 6 to 8 weeks; however, patients experience functional gains over the next 3 to 6 months, with sustained functional improvement. Achieved improvement is permanent; patients do not experience worsening of the achieved improvement. Repeated cord blood infusions might lead to further functional benefits.
Risks : Low rate of potential side effects, such as
- varied tastes
- allergic reactions
Almost all of these reactions are only short-term and mostly related to DMSO (Dimethylsulfoxide), a cryoprotective agent that is dissolved rapidly in the patient’s body. Pre-medication including anti-histamines before the umbilical cord blood treatment significantly reduces the frequency as well as the intensity of these potential side effects.
After care : After completion of our therapy and being back home, we recommend subsequent neurorehabilitation (physical therapy, occupational therapy, etc.) for at least next 2 – 3 months. The synergy of cord blood regenerative chemistry and neurorehabilitation will boost neuroplasticity and post-stroke brain repair.
In addition, our doctors will be in contact with patient over the next 6 months to monitor treatment effectiveness and any potential adverse effects.
Learn more about Umbilical Cord Blood Treatment